When the Balance Sheet Becomes the Story
A portfolio company loses its largest customer. Revenue falls sharply in the back half of the year, and the finance team flags the event as a potential impairment indicator. By the time the external auditors arrive, management has produced an internal memo estimating that the customer relationship asset, originally recorded at $8 million in the purchase price allocation, remains fully recoverable. The auditors ask for the methodology behind that conclusion. The assumptions underpinning the original valuation and the assumptions driving the recoverability analysis are not reconciled. What follows is several compressed weeks of back-and-forth, a revised estimate, and an uncomfortable conversation with the audit committee about why the asset had not been tested sooner.
That dynamic (reactive, compressed, and difficult to explain in the moment) is the environment that intangible asset impairment testing is designed to prevent. For fund managers, CFOs, and their advisors, an analytical framework to support impairment testing should already be in place when the triggering event arrives.
Practitioners who approach impairment testing with the same rigor applied at acquisition are better positioned to respond with clarity when it matters most, whether that moment arrives at the audit table, in an LP update, or at the closing of a transaction.
Carrying Value Under Scrutiny: What Impairment Testing Actually Is
Intangible asset impairment testing is a formal accounting and valuation process required under U.S. GAAP to assess whether the carrying value of a recorded intangible asset continues to be supported by its economic utility. Under ASC 350 (for indefinite-lived intangibles and goodwill) and ASC 360 (for long-lived assets held and used), companies must evaluate whether certain assets have declined in value below their recorded amounts, and, if so, recognize a write-down. The test is required at least annually for indefinite-lived intangibles and is triggered for long-lived assets whenever specific impairment indicators are present, such as a significant decline in revenue, a change in the asset's use, or a deterioration in market conditions. The analysis differs meaningfully depending on the asset type: a trade name is typically tested using a relief-from-royalty approach that measures the value of not paying for a license; a customer relationship is assessed using a multi-period excess earnings framework that isolates the cash flows attributable specifically to that relationship; technology assets may be evaluated under income or cost methodologies depending on the nature of the asset and the availability of market data.
The central question impairment testing answers is straightforward: does the asset on the balance sheet still reflect its economic value? But the analytical process required to answer that question rigorously (with methodology, documentation, and defensibility) is substantially more complex than the question suggests.
The Cost of Deference: Why Independent Analysis Is Not Optional
Internal finance teams are well-positioned to identify impairment indicators and to prepare initial estimates. What they typically cannot provide is the independence and methodological consistency that auditors require to accept a recoverability conclusion without further scrutiny. The problem is the inherent conflict of interest in asking the same team responsible for the asset to assess whether it has declined in value. External auditors are aware of this dynamic, and their documentation expectations have grown accordingly. Internal memos that assert full recoverability without a documented valuation methodology are, at best, a starting point. At worst, they invite the very rounds of revision that impairment testing is designed to preempt.
Relying on legal or tax advisors to fill this gap also presents limitations. Those professionals are not positioned to conduct the quantitative valuation analysis (the income projections, discount rate development, and methodology selection) that satisfies ASC 350 and ASC 360 requirements. The gap between what an attorney or CPA can document and what an auditor is asking for is precisely the space that independent valuation advisory fills.
Doing nothing (deferring any formal analysis until a triggering event makes it unavoidable) produces the worst outcome. At that point, the engagement must be completed under time pressure, assumptions must be defended in real time, and the risk of a write-down being disclosed on an accelerated timeline increases substantially. For fund managers preparing LP reports or approaching a secondary transaction, an undocumented intangible asset carrying value can create friction at precisely the moment when a clean balance sheet matters most.
From Background Knowledge to Active Requirement: Recognizing the Moment
Intangible asset impairment testing moves from general awareness to operational priority in several specific circumstances:
A triggering event occurs. Revenue declines materially, a major customer relationship ends, a restructuring is announced, or a market capitalization falls below book value. Each of these is a recognized impairment indicator under GAAP and requires immediate assessment of affected assets.
An annual test is required. ASC 350 mandates annual impairment testing for goodwill and indefinite-lived intangible assets. When management determines that a qualitative assessment is insufficient to support a conclusion, a quantitative test is required.
A transaction is being structured. A buyer or lender conducting due diligence will scrutinize the carrying values of recorded intangibles. Assets that have never been tested post-acquisition represent a balance sheet risk that can surface as a valuation dispute at a critical deal stage.
Auditors issue a documentation request. When external auditors request support for recoverability conclusions on long-lived intangibles, the absence of an independent analysis creates the conditions for multiple rounds of revision and potential audit delays.
LP reporting or a secondary transaction is approaching. Fund managers preparing quarterly or annual LP communications (or positioning a portfolio company for a secondary sale) benefit from carrying values that are independently supported and can withstand investor scrutiny.
What Practitioners Should Weigh: Key Analytical Considerations
Asset Classification Drives Methodology
The analytical approach to impairment testing is not uniform. Whether an intangible asset is classified as definite-lived or indefinite-lived determines which accounting standard applies and shapes the structure of the test. Definite-lived assets (customer relationships, non-compete agreements, favorable contracts) are tested under a two-step recoverability framework: first comparing carrying value to undiscounted future cash flows, then, if the asset fails that test, measuring the impairment as the excess of carrying value over fair value. Indefinite-lived assets, such as trade names, are tested annually for impairment using a fair value approach. Misclassifying an asset or applying the wrong testing framework creates documentation exposure that auditors are trained to identify.
Methodological Consistency with the Original PPA
Impairment analyses that are methodologically inconsistent with the purchase price allocation that established the original carrying value invite questions about the integrity of both analyses. If a customer relationship asset was valued under a multi-period excess earnings approach at acquisition, the impairment test should apply the same framework, updated for current conditions rather than rebuilt from a different analytical starting point. This consistency reduces the reconciliation burden during audit and supports a more coherent narrative if the asset's value has genuinely changed.
Discount Rate and Projection Assumptions Are Where Scrutiny Concentrates
In any income-based impairment analysis, the assumptions that most directly affect the conclusion, and that receive the most scrutiny, are the revenue and cash flow projections and the discount rate applied to them. Projections that are materially inconsistent with recent performance or with management's own forward guidance are difficult to defend. Discount rates that have not been updated to reflect current market conditions can result in conclusions that appear favorable but are analytically unsupported. Practitioners should expect these two inputs to be the focus of auditor review.
Timing Shapes the Quality of the Analysis
Impairment analyses completed proactively (before a triggering event, during the annual cycle, or as part of an ongoing monitoring framework) produce better analytical outcomes than those conducted under deadline pressure. When an engagement must be completed in weeks rather than months, the quality of the underlying data, the depth of scenario analysis, and the robustness of the documentation are all constrained by time. Practitioners who establish an impairment testing cadence in advance are better positioned to manage audit timelines and to respond to unexpected events without disruption.
The Houlihan Capital Approach: Methodology That Follows the Asset
Houlihan Capital's approach to intangible asset impairment testing is built on a structural advantage: the firm's valuation professionals work at the intersection of purchase price allocation and impairment advisory. In practice, this means that when a Houlihan team conducts an impairment analysis, they are applying the same asset-level methodology that established the original carrying value, updated for current operating and market conditions rather than rebuilt from a different analytical foundation. This continuity reduces the reconciliation burden when auditors compare the impairment conclusion against the original PPA, and it supports a coherent, auditable documentation trail from acquisition through each subsequent testing cycle.
Houlihan structures impairment engagements around the specific asset type and its corresponding valuation methodology (relief-from-royalty for trade names, multi-period excess earnings for customer relationships, and income or cost approaches for technology assets) rather than applying a single generic model across an intangible asset portfolio. This specificity matters because auditors evaluate the appropriateness of the methodology. An impairment analysis that can demonstrate why the selected approach is appropriate for the asset in question is substantially more defensible than one that applies a standard framework without that justification.
It is also worth distinguishing this service from Houlihan Capital's other valuation offerings. An ASC 820 portfolio valuation addresses the fair value of equity interests held by a fund, a fund-level analysis tied to LP reporting and investment company accounting. A purchase price allocation establishes the initial fair value of assets and liabilities at the time of a transaction. Intangible asset impairment testing is a distinct engagement: an asset-level analysis conducted at a specific point in the holding period to determine whether a recorded value remains supportable. The question being answered is different, the triggering conditions are different, and the documentation requirements are different. Practitioners who conflate these engagements risk addressing the wrong standard at the wrong stage of the asset's life.
What a Rigorous Process Makes Possible
Practitioners who engage in a well-structured impairment testing process walk away with something more durable than a completed analysis. They have a documented, methodology-grounded position on each intangible asset's carrying value, one they can place in front of an auditor, an LP, or a transaction counterparty and defend on its analytical merits. When those conversations arrive, the difference between an internally generated estimate and an independently supported conclusion is the difference between a clean response and a prolonged discussion about process.
Fund managers, CFOs, and their advisors who establish an impairment testing discipline are better positioned at every stage of the asset lifecycle. They enter audit cycles with documentation already in hand. They approach LP communications with balance sheet positions that are analytically grounded. And when a transaction emerges, they are not scrambling to explain why a recorded intangible has never been tested since the day it was acquired.
Start the Conversation
To learn more about intangible asset impairment testing or to discuss how it fits within an existing valuation framework, contact:
Amanda Nunley
Senior Vice President
anunley@houlihancapital.com
